Associated Papers
Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups.
Bolli N et al.
Leukemia, 2018
29789651 (PubMed )
Supplement: 41375_2018_37_MOESM14_ESM.xlsx › supp_Table1
Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer.
Lawrence B et al.
Npj Genomic Medicine, 2018
30062048 (PubMed )
Supplement: 41525_2018_58_MOESM2_ESM.xlsx › Table_S5
A pathway-centric survey of somatic mutations in Chinese patients with colorectal carcinomas.
Ling C et al.
Plos One, 2015
25617745 (PubMed )
Supplement: pone.0116753.s002.xlsx › table_s2
ErbB polymorphisms: insights and implications for response to targeted cancer therapeutics.
Alaoui-Jamali MA et al.
Frontiers in Genetics, 2015
25699077 (PubMed )
Supplement: Table1.PDF
Select a paper to view details